Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis

BACKGROUND: It is estimated that acute bacterial skin and skin structure infections (ABSSSI) account for nearly 10% of hospital admissions and 3.4-3.8 million emergency department visits per year in the United States. Analyses of hospital discharge records indicate 74% of ABSSSI admissions involve e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Ivar S., Wu, Elizabeth, Fan, Weihong, Lodise, Thomas P., Nicolau, David P., Dufour, Scott, Cyr, Philip L., Sulham, Katherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397907/
https://www.ncbi.nlm.nih.gov/pubmed/27231802
http://dx.doi.org/10.18553/jmcp.2016.22.6.752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397907/
https://www.ncbi.nlm.nih.gov/pubmed/27231802
http://dx.doi.org/10.18553/jmcp.2016.22.6.752

Ejemplares similares